I feel privileged now hearing thatIt’s a rare juice everywhere. Manufactured in much lower quantities than all the other vaccines.
I feel privileged now hearing thatIt’s a rare juice everywhere. Manufactured in much lower quantities than all the other vaccines.
No option for the people who will never have the vaccine on the survey. Are they statistically insignificant?
Not all deaths are equal?Not just statistically!
I feel privileged now hearing that
The kids are ok now. Mrs blunder has a cough but it’s quite mild and starting to go away.No good feeling privileged if you all catch covid! Are you/the missus over your cough/fever?
Covered by the + in 10 years +No option for the people who will never have the vaccine on the survey. Are they statistically insignificant?
Booster.Booster? Or second shot?
There's no evidence of that scale of problem with AZ. Provisional analysis suggest it does lose some efficacy but the level of protection against symptomatic disease after two doses is high, and it looks like it's doing an extremely good job of keeping people out of hospital even after one dose (+3 weeks). You may well find that your AZ appointment gets brought forward though, as the UK will be in AZ surplus soon and there is an incentive to get people double dosed because of the variants.So now I'm on AZ course of treatment. But from what I know about its protection against India Varient or whatever letter that's called now, two doses of AZ isn't as good as one dose of Pfizer. Someone may tell me I'm wrong which would be good.
Anyway so now I have to wait 10 weeks for 2nd AZ dose but I'm hoping that we'll all get a Pfizer booster before Xmas. They've bought 60m doses of it.
Good to know. But is all you've written there based on the Kent variant or Indian variant?There's no evidence of that scale of problem with AZ. Provisional analysis suggest it does lose some efficacy but the level of protection against symptomatic disease after two doses is high, and it looks like it's doing an extremely good job of keeping people out of hospital even after one dose (+3 weeks). You may well find that your AZ appointment gets brought forward though, as the UK will be in AZ surplus soon and there is an incentive to get people double dosed because of the variants.
Booster dose trials are already underway, but I doubt that they've got enough data on efficacy, variants or the need for boosters, to work out the rollout timing yet.
Yep, I was talking about the Indian/delta variant. The symptoms data is provisional with big error bars, the hospitalisation data is statistically stronger (because "usually" it's over 60s who get hospitalised and it's them who've mostly had two doses of AZ). Initial data suggests efficacy of AZ is about 35% after one dose rising to 60% one week after the second dose - for symptomatic cases. Pfizer is more like 35% one dose, 88% two doses. However from past data against the Kent/B117 variant, AZ generally takes longer to reach its maximum efficacy, so it's possible that's an underestimate.Good to know. But is all you've written there based on the Kent variant or Indian variant?
What I'm scared of / annoyed about is if the Indian variant proves to bypass AZ much more easily than it does Pfizer.
Laissez faire attitude, the government doesn't have a clue about preventing spread beyond needles in arms. The problem can't simply be solved by spending.What is it about the UK that's letting these variants rip through the population so much more quickly than elsewhere? 3 of the 8 most concerning variants originated there and 2 of the others hit the UK harder than just about anywhere else.
We're the only ones testing for it?What is it about the UK that's letting these variants rip through the population so much more quickly than elsewhere? 3 of the 8 most concerning variants originated there and 2 of the others hit the UK harder than just about anywhere else.
We're the only ones testing for it?
Was a genuine question. I'm on holiday so not really keeping up with the news? Is the rest of the world sequencing all their PCR tests ?
No. Denmark are world leaders at 100% and we’re next at over 50%. Oddly enough both countries picked up the Indian variant first.Was a genuine question. I'm on holiday so not really keeping up with the news? Is the rest of the world sequencing all their PCR tests ?
So does the rest of Europe have less delta variant or are they just not testing it?No. Denmark are world leaders at 100% and we’re next at over 50%. Oddly enough both countries picked up the Indian variant first.
I don’t think they’re as far along as we are in terms of it taking over from Kent. It will take over though - as it will in the US - in the next few weeks.So does the rest of Europe have less delta variant or are they just not testing it?
A lot less. Denmark is at 0.5% for instance (might have risen since last update but less than 3% anyway). Plenty other countries also sequence enough but less than UK. Will take couple of weeks for it to be dominant in mainland Europe.So does the rest of Europe have less delta variant or are they just not testing it?
But....A lot less. Denmark is at 0.5% for instance (might have risen since last update but less than 3% anyway). Plenty other countries also sequence enough but less than UK. Will take couple of weeks for it to be dominant in mainland Europe.
Probably both. Fewer seed cases with fewer travellers returning from the subcontinent back in April. Less routine genetic sequencing as well - in some countries only hospitalised cases, or cluster outbreaks are likely to be sequenced, in others testing will be running in research labs only and the results are often lagging behind live cases by a month or more.So does the rest of Europe have less delta variant or are they just not testing it?
Yep, I was talking about the Indian/delta variant. The symptoms data is provisional with big error bars, the hospitalisation data is statistically stronger (because "usually" it's over 60s who get hospitalised and it's them who've mostly had two doses of AZ). Initial data suggests efficacy of AZ is about 35% after one dose rising to 60% one week after the second dose - for symptomatic cases. Pfizer is more like 35% one dose, 88% two doses. However from past data against the Kent/B117 variant, AZ generally takes longer to reach its maximum efficacy, so it's possible that's an underestimate.
Certainly the hospitalisation data suggests very high protection against the variant.
The 3% is the upper limit. I would use 1.5% if I had to make a guess, and UK is closer to 90% so you can multiple your difference by about 4. So that would be around 15x difference. Which would probably be 4-6 weeks before Denmark catches up.But....
Isn't Denmark on 116 cases per 100k people whereas it's 26 cases per 100k people in the UK.
So looking only at Delta variants, and taking 3% of cases in Denmark Vs 50% in the UK, which I'm not saying are good figures to go by, then it's 3 cases per 100k of India in Denmark Vs 13 per 100k in the UK.
Is your inference taking into account the information in this thread which is from today? I clicked through and I can see it says "highly of uncertainty around Oxford-AZ vaccine" but no other information is provided.
Is your inference taking into account the information in this thread which is from today? I clicked through and I can see it says "highly of uncertainty around Oxford-AZ vaccine" but no other information is provided.
That report was very doom and gloom but this is rather good news surely?
What percentage have had both doses in the U.K.? 3.7 percent sounds small but I don’t know how much that under indexes on the segment with two doses..Yep. This is a race between the vaccine and the virus, which for the UK is a way better position to be in than we were 6 months ago. Depressing though.
Just over 26 million people.What percentage have had both doses in the U.K.? 3.7 percent sounds small but I don’t know how much that under indexes on the segment with two doses..
During the period covered by the report around a third of the UK population had had two doses.What percentage have had both doses in the U.K.? 3.7 percent sounds small but I don’t know how much that under indexes on the segment with two doses..
How are you feeling? I'm having it on Sunday and there's not that many first hand accounts here from people who've had ModernaHad my first jab earlier. Ended up with the Moderna which was a bit surprising. Thought it would likely be Phizer.
This is quite technical but take home message seems to be it looks likely that vaccine resistance with Delta (Indian) variant similar to Beta (South African). So this latest variant is as bad or worse than any other in terms of all three criteria (transmissibility, severity and vaccine resistance ) Basically an absolute cnut.